Juvenescence
Juvenescence is an AI-driven drug discovery platform founded in 2016 by Jim Mellon, Declan Doogan and Greg Bailey.
5
Funding Rounds
$238.3m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ji* Me**** |
|
- | |
| De**** Do**** |
|
- | - |
| Gr** Ba**** |
|
- | - |
Funding series
Funding Series Analysis
The company Juvenescence has raised a total of $76m in funding over 5 rounds.
Key Insights:
- Juvenescence Series B Round, May 2025: $76m
- Juvenescence funding round, August 2019: $100m
- Juvenescence funding round, June 2018: $50m
- Juvenescence funding round, January 2018: $12.3m
Juvenescence Series B Round, May 2025
$76m
Juvenescence funding round, August 2019
$100m
Juvenescence funding round, June 2018
$50m
Juvenescence funding round, January 2018
$12.3m
Industries
Juvenescence is active in the following industries: